Muscular dystrophies due to glycosylation defects: Diagnosis and therapeutic strategies

Current Opinion in Neurology

Volumn 24, Issue 5, 2011, Pages 437-442

  Muntoni, Francesco ^a   Torelli, Silvia ^a   Wells, Dominic J ^b   Brown, Susan C ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Animal models; congenital muscular dystrophies; dystroglycan; glycosylation; therapeutic strategies

Indexed keywords

ALPHA DYSTROGLYCAN; CORTICOSTEROID; GLYCOSYLTRANSFERASE;

CENTRAL NERVOUS SYSTEM; DAG1 GENE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROGLYCANOPATHY; EXPERIMENTAL MOUSE; EYE; GENE; GENE MUTATION; GENETIC DISORDER; GLYCOSYLATION; HUMAN; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN FOLDING; REVIEW; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; GLYCOSYLATION; HUMANS; MICE; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; WALKER-WARBURG SYNDROME; ZEBRAFISH;

EID: 80052472115     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32834a95e3     Document Type: Review

References (46)

1. Hayashi YK, Ogawa M, Tagawa K, et al. Selective deficiency of alphadystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001; 57:115-121. (Pubitemid 32634859)
2. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 2011; 364:939-946.
3. Henry MD, Campbell KP. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996; 8:625-631. (Pubitemid 26381719)
4. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: posttranslational processing and dystroglycan function. J Biol Chem 2003; 278: 15457-15460. (Pubitemid 36799650)
5. Holt KH, Crosbie RH, Venzke DP, Campbell KP. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett 2000; 468:79-83. (Pubitemid 30101686)
6. McDearmon EL, Combs AC, Ervasti JM. Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding. J Biol Chem 2003; 278:44868-44873. (Pubitemid 37377246)
7. Martin PT. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology 2003; 13:55R-66R. (Pubitemid 36939570)
8. Endo T, Manya H. O-mannosylation in mammalian cells. Methods Mol Biol 2006; 347:43-56.
9. Hoyte K, Kang C, Martin PT. Definition of pre and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT galnac transferase in mouse tissues. Brain Res Mol Brain Res 2002; 109:146-160. (Pubitemid 36078380)
10. Smalheiser NR, Kim E. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J Biol Chem 1995; 270:15425-15433.
11. Smalheiser NR, Haslam SM, Sutton-Smith M, et al. Structural analysis of sequences O-linked to mannose reveals a novel lewis X structure in cranin (dystroglycan) purified from sheep brain. J Biol Chem 1998; 273:23698-23703. (Pubitemid 28435699)
12. Colognato H, Winkelmann DA, Yurchenco PD. Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 1999; 145:619-631. (Pubitemid 29215724)
13. Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn 2000; 218:213-234. (Pubitemid 30349637)
14. Yurchenco PD, Cheng YS, Campbell K, Li S. Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy. J Cell Sci 2004; 117:735-742. (Pubitemid 38263218)
15. Combs AC, Ervasti JM. Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation. Biochem J 2005; 390:303-309. (Pubitemid 41192256)
16. Brown SC, Fassati A, Popplewell L, et al. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J Cell Sci 1999; 112:209-216. (Pubitemid 29078355)
17. Yoshida-Moriguchi T, Yu L, Stalnaker SH, et al. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 2010; 327:88-92.
18. Stalnaker SH, Hashmi S, Lim JM, et al. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem 2010; 285:24882-24891.
19. Lefeber DJ, Schonberger J, Morava E, et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet 2009; 85:76-86.
20. Aiello C, Morava E, Concolino D, et al. Novel alpha dystroglycanopathy caused by a deficiency of Dol-P-Man Synthase subunit DPM2 in two inbred sibs causing a severe early onset epileptic encephalopathy. 15th World Muscle Society Congress, Kumamoto Japan; September 2010.
21. Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007; 130:2725-2735. (Pubitemid 47511718)
22. Jimenez-Mallebrera C, Torelli S, Feng L, et al. A comparative study of alphadystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol 2009; 19:596-611.
23. Clement E, Mercuri E, Godfrey C, et al. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008; 64:573-582.
24. Williamson RA, Henry MD, Daniels KJ, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997; 6:831-841. (Pubitemid 27239066)
25. Willer T, Prados B, Falcon-Perez JM, et al. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc Natl Acad Sci USA 2004; 101:14126-14131. (Pubitemid 39305041)
26. Kurahashi H, Taniguchi M, Meno C, et al. Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol Dis 2005; 19:208-217. (Pubitemid 40544738)
27. Chan YM, Keramaris-Vrantsis E, Lidov HG, et al. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. Hum Mol Genet 2010; 19:3995-4006.
28. Hu H, Li J, Gagen CS, et al. Conditional knockout of protein O-mannosyltransferase reveals tissue-specific roles ofO-mannosyl glycosylation in brain development. J Comp Neurol 2011; 519:1320-1337.
29. Moore SA, Saito F, Chen J, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002; 418:422-425. (Pubitemid 34826842)
30. Satz JS, Barresi R, Durbeej M, et al. Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J Neurosci 2008; 28:10567-10575.
31. Satz JS, Ostendorf AP, Hou S, et al. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci 2010; 30:14560-14572.
32. Kanagawa M, Nishimoto A, Chiyonobu T, et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum Mol Genet 2009; 18:621-631.
33. Ackroyd MR, Skordis L, Kaluarachchi M, et al. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009; 132:439-451.
34. Han R, Kanagawa M, Yoshida-Moriguchi T, et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci USA 2009; 106:12573-12579.
35. Gumerson JD, Kabaeva ZT, Davis CS, et al. Soleus muscle in glycosylationdeficient muscular dystrophy is protected from contraction-induced injury. Am J Physiol Cell Physiol 2010; 299:C1430-1440.
36. Moore CJ, Goh HT, Hewitt JE. Genes required for functional glycosylation of dystroglycan are conserved in zebrafish. Genomics 2008; 92:159-167.
37. Thornhill P, Bassett D, Lochmuller H, et al. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP). Brain 2008; 131:1551-1561. (Pubitemid 351806461)
38. Kawahara G, Guyon JR, Nakamura Y, Kunkel LM. Zebrafish models for human FKRP muscular dystrophies. Hum Mol Genet 2010; 19:623-633.
39. Lin YY, White RJ, Torelli S, et al. Zebrafish fukutin family proteins link the unfolded protein response with dystroglycanopathies. Hum Mol Genet 2011; 20:1763-1775.
40. Avsar-Ban E, Ishikawa H, Manya H, et al. Protein O-mannosylation is necessary for normal embryonic development in zebrafish. Glycobiology 2010; 20:1089-1102.
41. Gupta V, Kawahara G, Gundry SR, et al. The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies. Hum Mol Genet 2011; 20:1712-1725.
42. Godfrey C, Escolar D, Brockington M, et al. Fukutin gene mutations in steroidresponsive limb girdle muscular dystrophy. Ann Neurol 2006; 60:603-610. (Pubitemid 44871803)
43. Muntoni F, Guicheney P, Voit T. 158th ENMC international workshop on congenital muscular dystrophy (Xth international CMD workshop) 8th-10th February 2008 Naarden, the Netherlands. Neuromuscul Disord 2009; 19:229-234.
44. Barresi R, Michele DE, Kanagawa M, et al. Large can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 2004; 10:696-703. (Pubitemid 38937634)
45. Brockington M, Torelli S, Sharp PS, et al. Transgenic overexpression of large induces alpha-dystroglycan hyperglycosylation in skeletal and cardiac muscle. PLoS One 2010; 5:e14434.
46. Zhang Z, Zhang P, Hu H. Large expression augments the glycosylation of glycoproteins in addition to alpha-dystroglycan conferring laminin binding. PLoS One 2011; 6:e19080.